NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$58.00 +1.82 (+3.24 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$58.00
Today's Range$55.81 - $58.32
52-Week Range$28.55 - $91.16
Volume197,078 shs
Average Volume455,187 shs
Market Capitalization$1.19 billion
P/E Ratio-1,450.00
Dividend YieldN/A
Beta1.79
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$134.55 million
Cash Flow$0.5160 per share
Book Value$6.86 per share

Profitability

Net Income$14.29 million

Miscellaneous

Employees536
Market Cap$1.19 billion
Next Earnings Date2/28/2019 (Confirmed)
OptionableOptionable

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) posted its quarterly earnings data on Tuesday, August, 7th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.12. The firm earned $48.60 million during the quarter, compared to analysts' expectations of $46.73 million. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Thursday, February 28th 2019. View Earnings Estimates for Tabula Rasa HealthCare.

What price target have analysts set for TRHC?

10 analysts have issued twelve-month price targets for Tabula Rasa HealthCare's stock. Their forecasts range from $47.00 to $100.00. On average, they anticipate Tabula Rasa HealthCare's share price to reach $85.8889 in the next year. This suggests a possible upside of 48.1% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.

What is the consensus analysts' recommendation for Tabula Rasa HealthCare?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

What are Wall Street analysts saying about Tabula Rasa HealthCare stock?

Here are some recent quotes from research analysts about Tabula Rasa HealthCare stock:
  • 1. According to Zacks Investment Research, "Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. " (1/22/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating and $99 12-month price target on TRHC shares. Rasa reported solid third quarter results, which were generally above our estimates and FactSet consensus. The company’s top-line beat was driven by recent acquisitions and higher pharmacy cost management (PCM) revenue due to a change regarding TRHC’s data aggregation partner. The company’s recent acquisitions contributed modestly to revenue. While TRHC provided general comments regarding 2019, it did not provide full guidance." (11/6/2018)

Has Tabula Rasa HealthCare been receiving favorable news coverage?

News coverage about TRHC stock has been trending somewhat positive recently, InfoTrie reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tabula Rasa HealthCare earned a news impact score of 1.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Adobe (ADBE), Workday (WDAY), salesforce.com (CRM), Micron Technology (MU), Netflix (NFLX), Alibaba Group (BABA), ServiceNow (NOW), Align Technology (ALGN) and Splunk (SPLK).

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)
  • Mr. Brian W. Adams, CFO & Sec. (Age 37)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.71%), Jennison Associates LLC (3.69%), M&T Bank Corp (2.59%), Ranger Investment Management L.P. (2.32%), Macquarie Group Ltd. (1.54%) and Bank of New York Mellon Corp (1.37%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Glen R Bressner, Gordon Tunstall, Growth Fund 1Q Lp Originate, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which major investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Timpani Capital Management LLC, Voloridge Investment Management LLC, Barclays PLC, Granite Investment Partners LLC, Tygh Capital Management Inc., Gemmer Asset Management LLC, Intrinsic Edge Capital Management LLC and Eagle Asset Management Inc.. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which major investors are buying Tabula Rasa HealthCare stock?

TRHC stock was purchased by a variety of institutional investors in the last quarter, including M&T Bank Corp, Macquarie Group Ltd., Polar Capital LLP, First Trust Advisors LP, BlackRock Inc., New York State Common Retirement Fund, Fiera Capital Corp and SG Americas Securities LLC. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams, Glen R Bressner and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $58.00.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.19 billion and generates $134.55 million in revenue each year. The company earns $14.29 million in net income (profit) each year or ($0.04) on an earnings per share basis. Tabula Rasa HealthCare employs 536 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  210 (Vote Outperform)
Underperform Votes:  185 (Vote Underperform)
Total Votes:  395
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel